Literature DB >> 25599021

Molecular mechanisms involved in tumor repopulation after radiotherapy.

Wooi-Loon Ng1, Qian Huang1, Xinjian Liu1, Mary Zimmerman1, Fang Li1, Chuan-Yuan Li1.   

Abstract

Radiotherapy remains one of most important treatment modalities for solid tumors. Current radiotherapy is mostly based on a set of concepts called the 4"R"s, which were established when there was lack of understanding of the underlying molecular mechanisms. However, progress made in the past two decades are beginning to allow us to see some of the molecular details involved in tumor response to radiation therapy. In this review, we will attempt to summarize some of the key discoveries in molecular radiation biology that have direct relevance to radiotherapy. We will focus our discussion on areas such as radiation induced tumor vasculogenesis, stem cell mobilization, and cellular repopulation. We hope our discussion will stimulate further studies in this important area of cancer research.

Entities:  

Keywords:  4“R”s; Radiation therapy; phoenix rising pathway; tumor repopulation; vasculogenesis

Year:  2013        PMID: 25599021      PMCID: PMC4293635          DOI: 10.3978/j.issn.2218-676X.2013.10.03

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


  36 in total

1.  Treatment-Induced Accelerated Human Tumor Growth.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1993-04       Impact factor: 5.934

2.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.

Authors:  D Lyden; K Hattori; S Dias; C Costa; P Blaikie; L Butros; A Chadburn; B Heissig; W Marks; L Witte; Y Wu; D Hicklin; Z Zhu; N R Hackett; R G Crystal; M A Moore; K A Hajjar; K Manova; R Benezra; S Rafii
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Impact of stromal sensitivity on radiation response of tumors.

Authors:  W Budach; A Taghian; J Freeman; D Gioioso; H D Suit
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

6.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Authors:  John M Heddleston; Zhizhong Li; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

7.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

8.  Enhanced c-Fms/M-CSF receptor signaling and wound-healing process in bone marrow-derived macrophages of signal-transducing adaptor protein-2 (STAP-2) deficient mice.

Authors:  Osamu Ikeda; Yuichi Sekine; Ryuta Muromoto; Norihiko Ohbayashi; Akihiko Yoshimura; Tadashi Matsuda
Journal:  Biol Pharm Bull       Date:  2008-09       Impact factor: 2.233

9.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.

Authors:  Qian Huang; Fang Li; Xinjian Liu; Wenrong Li; Wei Shi; Fei-Fei Liu; Brian O'Sullivan; Zhimin He; Yuanlin Peng; Aik-Choon Tan; Ling Zhou; Jingping Shen; Gangwen Han; Xiao-Jing Wang; Jackie Thorburn; Andrew Thorburn; Antonio Jimeno; David Raben; Joel S Bedford; Chuan-Yuan Li
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

10.  M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Authors:  Yoshiaki Kubota; Keiyo Takubo; Takatsune Shimizu; Hiroaki Ohno; Kazuo Kishi; Masabumi Shibuya; Hideyuki Saya; Toshio Suda
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307

View more
  7 in total

1.  Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy.

Authors:  M Giuliani; L R Sampson; O Wong; J Gay; L W Le; B C J Cho; A Brade; A Sun; A Bezjak; A J Hope
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

2.  High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.

Authors:  Chotaro Onaga; Shoma Tamori; Izumi Matsuoka; Ayaka Ozaki; Hitomi Motomura; Yuka Nagashima; Tsugumichi Sato; Keiko Sato; Kouji Tahata; Yuyun Xiong; Yoshio Nakano; Yasunari Mano; Satoru Miyazaki; Kazunori Sasaki; Shigeo Ohno; Kazunori Akimoto
Journal:  Cancer Diagn Progn       Date:  2022-07-03

3.  DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation.

Authors:  Christopher P Allen; Walter Tinganelli; Neelam Sharma; Jingyi Nie; Cory Sicard; Francesco Natale; Maurice King; Steven B Keysar; Antonio Jimeno; Yoshiya Furusawa; Ryuichi Okayasu; Akira Fujimori; Marco Durante; Jac A Nickoloff
Journal:  Front Oncol       Date:  2015-12-07       Impact factor: 6.244

4.  Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts.

Authors:  Elodie Melsens; Elly De Vlieghere; Benedicte Descamps; Christian Vanhove; Ken Kersemans; Filip De Vos; Ingeborg Goethals; Boudewijn Brans; Olivier De Wever; Wim Ceelen; Piet Pattyn
Journal:  Radiat Oncol       Date:  2018-03-07       Impact factor: 3.481

5.  Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin.

Authors:  Heather E Kapperman; Alicia A Goyeneche; Carlos M Telleria
Journal:  Cancer Cell Int       Date:  2018-11-15       Impact factor: 5.722

6.  Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness.

Authors:  Lirong Zhang; Hui Shi; Hongbo Chen; Aihua Gong; Yanfang Liu; Lian Song; Xuewen Xu; Tao You; Xin Fan; Dongqing Wang; Fang Cheng; Haitao Zhu
Journal:  Cell Death Dis       Date:  2019-09-26       Impact factor: 8.469

Review 7.  Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance.

Authors:  Ewelina Dratkiewicz; Aleksandra Simiczyjew; Justyna Mazurkiewicz; Marcin Ziętek; Rafał Matkowski; Dorota Nowak
Journal:  Cells       Date:  2021-04-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.